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doi:10.1016/j.jtcvs.2005.10.021bjectives: Use of extracorporeal circuits in cardiopulmonary bypass and hemodi-
lysis often causes bleeding problems and hypotension. As shown previously, this
ight be caused by activation of blood platelets due to pumping. The present study
nvestigates the mechanism of pump-induced platelet aggregation and its possible
revention.
ethods and Results: Continuous measurement of platelet aggregation in an extra-
orporeal shunt from a carotid to a femoral artery in rats showed that aggregation
uring the first 10 minutes of pumping was not reduced by coating the tube with
lbumin or heparin nor by using dalteparin instead of unfractionated heparin as
nticoagulant. Also, pump characteristics seemed unimportant because aggregation
ould already be elicited by single tube compression with one pump roller. It was
alculated that during compression wall shear stress in the tube rises far beyond the
alues known to induce platelet aggregation, occurring also in clinically used roller
umps. A crucial role for adenosine diphosphate was demonstrated by blockade of
latelet adenosine diphosphate-P2Y12 receptors with the clinically used drug clo-
idogrel (50 mg/kg intravenously, n  8). This prevented platelet aggregation and
he fall of systemic blood pressure (to 71% 12% in controls, n 6) during 2 hours
f continuous pumping.
onclusion: We conclude that pump-induced platelet aggregation is not caused by
actors released from the tube or its coating but is initiated by short bouts of high
hear stress, and its continuation is critically dependent on adenosine diphosphate.
he latter might have clinical relevance for patients connected to extracorporeal
ystems.
se of extracorporeal systems in cardiopulmonary bypass and hemodialysis
often causes severe hypotension and excessive bleeding.1,2 Our work with
human and rat blood suggests that these problems may be largely caused by
latelet activation in the tubing of the pumps used.3,4 Autoperfusion did not affect
latelets or hemodynamics in an extracorporeal shunt from a carotid to a femoral
rtery of rats, but insertion of a roller pump immediately elicited strong platelet
ggregation, serotonin (5-HT) release, and systemic hypotension. Hypotension could be
revented with blockade of 5-HT2 receptors or by inhibition of nitric oxide (NO)
roduction, suggesting that the aortic pressure decrease resulted from endothelial
O, the release of which was triggered by serotonin from activated platelets.5
-HT2-receptor blockade did not affect the intensity of aggregation, indicating that
-HT had cardiovascular effects only and was not critically involved in the process
f platelet aggregation.
The mechanism of pump-induced platelet aggregation has not been fully clari-
ed. Activation of platelets in our setup was not due to hemolysis,3 blood-air
ontact, or cessation of flow in reservoirs. Platelets, however, might be stimulated
y factors released from the pump tubing or its coating or by high shear stress.
The Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 4 813
I
b
a
b
W
t
e
u
e
i
w
p
w
M
T
I
(
t
t
m
r
p
l
h
A
a
v
p
p
s
i
c
c
a
t
e
s
T
m
p
m
l
c
s
p
p
p
p
c
o
a
A
h
b
(
a
o
a
m
d
t
c
p
E
m
S
g
h
T
s
d
t
m
f
a
s
T
r
m
r
r
S
v
h
o
T
S
V
d
o
Cardiopulmonary Support and Physiology Borgdorff and Tangelder
8
CSPnitiation of platelet activation by shear stress is suggested
y the absence of pump-induced platelet aggregation after
dministration of aurintricarboxylic acid,4 which inhibits
inding of a shear stress–exposed A1 domain of plasma von
illebrand factor (vWf) to platelet glycoprotein Ib recep-
ors.6,7 The present study therefore compared the pump
ffect in tubes coated with albumin or heparin to that in
ncoated tubes or tubes devoid of plasticizers. We also
stimated the time-varying magnitude of the shear stresses
n the pump tubing with the aid of a mathematical model;
e also investigated the contribution of adenosine diphos-
hate (ADP) by blocking platelet ADP-P2Y12 receptors
ith the clinically approved drug clopidogrel.
ethods
he experimental setup has been described in detail previously.5
n short, Wistar rats (330-450 g) were anesthetized with ketamine
60 mg/kg intramuscularly) and pentobarbital (35 mg/kg intraperi-
oneally, followed by 10-14 mg/kg per hour intravenously), ven-
ilated, and anticoagulated with unfractionated heparin (Leo Phar-
aceutical Products BV, Weesp, The Netherlands, 800 IU/kg). In
ats this dose is required when they are connected to an extracor-
oreal system. In one set of experiments animals were anticoagu-
ated with low-molecular-weight heparin (Dalteparin, Kabi, Stock-
olm, Sweden, 600 IU/kg). Body temperature was kept at 37.5°C.
ll animal handling was in compliance with the Guide for the Care
nd Use of Laboratory Animals (NIH publication no. 85-23, re-
ised 1985).
An extracorporeal shunt tube was placed between the proximal
art of a carotid and distal part of a femoral artery and loosely
ositioned in a roller pump with 8 rollers (see Appendix). Initial
pontaneous flow from carotid to femoral artery, measured with an
nline flow probe (1N, Transonic Systems Inc, Ithaca, NY), was
onverted to pump perfusion by tightening the rollers with a
alibrated screw just until flow stopped and by starting the pump
t a speed that restored flow to its original level. The calibration on
he screw allowed position of the rollers to be identical in all
xperiments. Aortic and femoral pressures were measured via
tainless steel T-pieces in the shunt at 30 mm from the cannulas.
o use the vascular bed of the leg as “bioassay,” we continuously
easured femoral resistance as the ratio of mean femoral artery
ressure over flow.
Platelet aggregation downstream of the pump was continuously
Abbreviations and Acronyms
ADP  adenosine diphosphate
CPB  cardiopulmonary bypass surgery
EDTA ethylenediamine tetraacetic acid
5-HT  serotonin
NO  nitric oxide
SD  standard deviation
SEM  standard error of the mean
vWf  von Willebrand factoreasured with a photometric device, which detects an increase in b
14 The Journal of Thoracic and Cardiovascular Surgery ● Apriight transmission when platelet aggregates pass through a glass
apillary.8 For quantitation the signals were converted to uniform
pikes and counted over 10-second periods. For comparison of
latelet count and volume before and after 2 hours of pump
erfusion a Helios blood cell counter (ABX Diagnostics, Mont-
ellier, France) was used.
In a first series of experiments we compared the intensity of
ump-induced platelet aggregation in 3 different circuits: un-
oated, coated with Duraflow-II heparin by Edwards Lifesciences,
r coated with albumin.9 In all subsequent experiments we used
lbumin-coating to minimize the effects of blood-material contact.
lbumin is as effective in this respect as heparin coating10,11 and
as the additional advantage that possible direct effects of surface-
ound heparin on platelets are avoided.
Clopidogrel, a potent platelet ADP-P2Y12-receptor antagonist
Sanofi-Synthelabo, Toulouse, France) was dissolved in saline and
dministered intravenously (50 mg/kg). To be effective, this thien-
pyridine compound was allowed to be metabolized in the liver for
t least 30 minutes12 before experiments started.
Stability of the platelet aggregates was studied in vitro with a
odification of the “Wu and Hoak-method”13: blood samples were
ivided in 2 parts of 0.1 mL, which were added to ethylenediamine
etraacetic acid (EDTA) solutions (0.4 mL) with different final
oncentrations. A concentration of 5 mmol/L EDTA was used to
revent further aggregation, and a concentration of 10 mmol/L
DTA was used to dissolve reversible aggregates. Within 30
inutes after blood collection a hemolysing agent (Thromboplus,
arstedt, Nümbrecht, Germany) was added and platelets and ag-
regates (larger than two clumped platelets) were counted with
elp of a Bürker counting chamber using brightfield microscopy.
he reliability of the method was verified on blood in which both
table and unstable aggregates were produced by adenosine 3,5-
iphosphate (ADP), in a final concentration of 40 mol/L. Pho-
ographs of the samples were made on a 3I Marianas inverted
icroscopy workstation (Denver, CO) using its differential inter-
erence contrast imaging modality.
The effect of a few or only a single tube occlusion on platelet
ggregation, without interrupting blood flow to the hind leg, was
tudied with aid of the same pump after removing 6 of the 8 rollers.
his made it possible to perform these compressions with the same
otation speed and occlusiveness of the roller, as in the experi-
ents with all rollers in place. In contrast to the situation with 8
ollers, autoperfusion is not taken over by the pump when 6 of 8
ollers are missing.
We employed a mathematical model, based on the Navier-
tokes equations, for estimation of time-varying wall shear stress
alues in the tubings of our experimental pump and a clinical
emodialysis pump; this model is an extension of a model previ-
usly used to estimate shear stress under static flow conditions.8
he model is presented in Appendix E1.
tatistics
alues in text, legends, and table are expressed as mean  stan-
ard deviation (SD); values in the figures as mean standard error
f the mean (SEM). For comparison of platelet counts and volume
efore and after pump perfusion (Table 1) the paired t test was
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Psed. Time series data under different conditions (Figure 1) were
nalyzed with 2-way analysis of variance for repeated
easurements.
esults
ump-Induced Platelet Aggregation Does Not Depend
n Tube Characteristics or Choice of Anticoagulant
lthough autoperfusion did not affect platelets or hemody-
amics, start of the pump immediately elicited strong plate-
et aggregation, which was maximal within the first 3 to 5
inutes. It then leveled off but remained present for the next
hours of pumping. Figure 1, A illustrates that the amount
f platelet aggregation in heparinized animals during the
rst 10 minutes after pump start was not significantly dif-
erent whether the system was coated with albumin or with
eparin or not coated at all. This illustrates that aggregation
oes not result from albumin or heparin released from the
oating during squeezing of the tube. Neither is the aggre-
ation initiated by release of plasticizers from the tubing,
ecause experiments with silicone or polyurethane tubing,
hich are devoid of plasticizers, yielded similar results (not
hown).
Also, anticoagulation with dalteparin instead of un-
ractionated heparin did not diminish platelet aggregation
Figure 1, B), indicating that the pump-induced platelet
ggregation did not depend on a specific influence of un-
Figure 1. A, Amount of platelet aggregation during the
albumin-coated tubes (n  6) and heparin-coated tube
anticoagulated with unfractionated heparin. Note the a
aggregation is also elicited in albumin-coated tubes
virtually absent after ADP-P2Y12-receptor blockade wiractionated heparin on platelet behavior. c
The Journal of Thoraciclatelet Aggregation Can Even Be Evoked by a Single
oller Compression
o study whether aggregation of platelets during pump
erfusion was an effect of the high frequency of tube
ompressions in the pump used, we reduced this frequency
rom 120/min to 30/min by removing 6 of 8 rollers from the
ump (n  5). Also with this lower compression frequency,
ut with the same roller speed as used in the experiments
ith 8 rollers, strong platelet aggregation was observed
Figure 2, left panel). Aggregation could also be elicited by
small series of separate compressions, and, interestingly,
ven by a single compression (Figure 2, middle and right
anel, respectively). Despite the short duration of a single
ompression, aggregation continued for 28  3.8 seconds
n  19) at 15 cm after the pump. Elongation of the tube
etween pump and aggregometer revealed that the duration
f aggregation increased with distance, to 143 16 (n  7)
econds at 75 cm. This indicates that aggregation inside the
ube was self-reinforcing.
Experiments with lengthened tubes also demonstrated
hat the propagation speed of the aggregates was only half
f mean blood velocity in the first 15 cm; the propagation
peed then increased and exceeded mean blood velocity
fter about 55 cm. This indicates that the aggregates move
lose to the tube wall within the first 15 cm and more
10 minutes of pump perfusion is similar (P  .53) for
6), as well as for uncoated (n  6) tubes in animals
ce of aggregation before pump start (t  0). B, Platelet
n dalteparin (n  7) is used as anticoagulant but is
opidogrel (n  8, P < .0001).first
s (n 
bsen
whe
th clentrally further on.
and Cardiovascular Surgery ● Volume 131, Number 4 815
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CSPFigure 2 additionally shows that blood flow to the hind
eg during platelet aggregation in these experiments in-
reased, and thus did not show the triphasic response
vasodilation—vasoconstriction—vasodilation) seen dur-
ng regular pumping (ie, when aggregation is more intense
nd more serotonin will be released). The vascular reaction
o serotonin depends on its concentration.5
hear Stress Values during a Single Tube
ompression in a Roller Pump
igure 3 presents shear stress values at the tube wall as a
unction of time or tube slit height for 2 different roller
umps. When the slit height in the pump tubing becomes
maller than about 20 m (see upper axis in Figure 3), the
hear stress values far exceed the level of about 120 dynes/
m2 reported to elicit platelet aggregation.7 The correspond-
Figure 2. Recordings of platelet aggregation elicited du
by 7 (middle panel) and by a single (right panel) tube
compression and decompression, together lasting abou
25 seconds (right panel). Upper tracing, Raw signal; mid
resulting increase of flow to the hind leg. In these expe
no driving effect on flow.ng time periods during every compression or decompres- r
16 The Journal of Thoracic and Cardiovascular Surgery ● Apriion of the tube are 25 ms in our small laboratory pump (A)
nd 17 ms in a clinical pump (B).
rucial Role for ADP: Prevention with Clopidogrel
lockade of platelet ADP-P2Y12 receptors with clopidogrel
n animals that were anticoagulated with unfractionated hepa-
in nearly completely prevented aggregation (Figure 1, B).
lso the 2-phasic fall in aortic pressure, in controls to
1%  12% (mean  SD) during the first 5 to 10 minutes
nd to 71%  12% at 2 hours of pumping, remained absent
Figure 4, A). Because the drops in aortic pressure are
nown to be elicited by platelet-released serotonin,5 their
bsence indicates that clopidogrel not only prevents platelet
ggregation but also impairs the release of serotonin.
Figure 4, B shows the effect of clopidogrel on the reac-
ion of femoral resistance. Although in controls femoral
autoperfusion by continuous repetitive (left panel) and
pression (visible in the flow tracing). Even a single
ms, is sufficient to elicit platelet aggregation for about
racing, quantification over 10-second periods. Note the
nts flow was not fixed because the adapted pump hadring
com
t 100
dle t
rimeesistance showed a triphasic pattern after pump start (a short
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Pecrease, a rise of 5-10 minutes to 141%  13%, and a
ong-lasting fall to 64%  14%), it only decreased in the
resence of clopidogrel.
ggregate Lability and Prevention of Platelet
oss by Clopidogrel
icroscopic inspection of blood samples from the return
ine in control experiments showed only single platelets
efore pump start (see Figure 5, A) but revealed many
ggregates (33  21  109/L, n  5) and a decrease in free
latelet number of 42%  15% after 1 minute of pumping.
he aggregates varied in size from duplets to platelet
lumps with a diameter of more than 100 m (for examples
ee Figure 5, B and C). However, as shown in Figure 5, D,
hese aggregates were not stabilized and could easily disin-
egrate, yielding a free platelet count similar to control
103% 10%). Though being labile, the aggregates did not
all apart in the tubing, as seen when the tube between pump
nd aggregometer was elongated from 15 to 75 cm (n  7).
Figure 3. Wall shear stresses in the tubing of the sma
AK 10 Gambro hemodialysis pump (B, 2 rollers). Flow w
respectively). The lower horizontal axis depicts the tim
axis indicates the slit height under a roller. The dotted
expected. Rotation rate of both pumps: 20 revolutions/ecause blood did not contain aggregates when it had g
The Journal of Thoracicassed the body (ie, at the entrance of the extracorporeal
ircuit), platelets most likely desegregated in the microcir-
ulation of hind leg and lungs.
The lability of the aggregates also appeared from platelet
ounts. After 2 hours of pumping, platelet loss in our control
xperiments was only 14% (from 844 59 to 695 91 109/L;
eans SD, n 7, P .0005), which is far less than the 42%
ecrease seen within the first minute after pump start (see
bove). The number of platelets did not significantly decrease
fter pretreatment with clopidogrel (884  59 to 874  67
09/L, n  8, P  .25), that is, in the absence of aggregation.
lopidogrel also prevented the reduction in platelet volume,
hich in control experiments amounted 3.2% (from 5.2 0.27
o 5.0  0.21 fL; P  .0005) and which indicates that the
latelets, despite their disaggregation, did not fully recover.
iscussion
he present study shows that pump-induced platelet aggre-
mp used for the present study (A, 8 rollers) and in an
et to be 3% to 5% of cardiac output (3 and 225 mL/min,
fore or after complete occlusion; the upper horizontal
represents the level above which aggregation can be
For further details see appendix.ll pu
as s
e be
line
min.ation occurs both with unfractionated heparin and with
and Cardiovascular Surgery ● Volume 131, Number 4 817
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alteparin anticoagulation and does not depend on the pres-
nce or type of coating or on plasticizers in the tubing.
herefore, pump-induced platelet activation seems, in the
bsence of subendothelial collagen and with negligible
emolysis,3 to not be initiated by agonists released from
he tubing but by a physical stimulus, for example, shear
tress. Aggregation could be elicited even by a single
ube compression and continued in the tubing behind the
ump, although the aggregates were unstable. The platelets
robably desegregated during passage through the micro-
irculation of the perfused leg because femoral resistance
howed, after an increase for some minutes, a long-lasting
ecrease, and no aggregates were observed in the blood that
eft the body. It was calculated that compression and de-
igure 4. Aortic pressure (A) and femoral resistance (B) after
nset of pump perfusion (t  0; mean  SEM). Clopidogrel
revented both the first and second hypotensive reaction as well
s the rise in femoral resistance (P< .001). It had no influence on
he long-lasting femoral vasodilation (P  .71). Initial aortic pres-
ures (mean  SD at time 0) were 137  15 (control, n  6) and
14  10 mm Hg (clopidogrel, n  8); the respective initial femoral
esistances were 58  17 and 60  12 mm Hg · min · mL1.ompression of the tube produced shear stresses that far p
18 The Journal of Thoracic and Cardiovascular Surgery ● Aprixceeded the values reported necessary for platelet aggre-
ation. We also demonstrated a crucial role for ADP by
reventing both platelet aggregation and the subsequent
ypotension with clopidogrel.
Accordingly, the proposed sequence of events leading to
ump-induced platelet aggregation is highlighted in Figure 6.
n high shear stress fields platelets are deformed and large
lasma multimers of vWf undergo a conformational change
rom a globular state into an extended chain, thereby pre-
enting their A1 domain that binds to platelet glycoprotein
b receptors.14,15 This starts platelet activation by mobiliza-
ion of calcium,16 which, among other factors, leads to re-
ease of ADP and serotonin from dense granules and of vWf
rom alpha granules.7 ADP stimulates purinergic P2Y12
eceptors on the membrane of the same and other platelets,
romoting aggregation by activation of platelet GPIIB/IIIA
eceptors that bind fibrinogen as well as the adhesive
lasma- and platelet-released vWf.6,17,18 At high shear
tresses (above 100 dynes/cm2) platelet aggregation be-
omes aspirin-insensitive,19,20 probably because mainly
he release of vWf from platelet alpha granules is stimu-
ated, which is not inhibited by aspirin.21
The initiating role of shear stress in pump-induced platelet
ggregation is corroborated by the absence of aggregation,
hen the vWf-GP1b receptor binding is blocked with aurin-
ricarboxylic acid or a recombinant vWf fragment,3 and by its
ow sensitivity to aspirin treatment (submitted). Furthermore,
ggregate formation could be successfully prevented by selec-
ive blockade of platelet ADP-P2Y12 receptors with clopi-
ogrel. A similar pivotal role of ADP has been demonstrated
or shear-induced platelet aggregation in vitro.17,22 Serotonin,
hich like ADP is also released from dense granules, does not
ontribute to the aggregation under these circumstances but has
ainly cardiovascular effects5 (Figure 6).
Clopidogrel did not prevent vasodilation in the femoral
ed of our rats (see Figure 4). This vasodilation may have
een caused by small amounts of serotonin5 and/or by ADP
eleased from activated but nonaggregating platelets. ADP
auses vasodilation via clopidogrel-insensitive P2Y1 recep-
ors in the vascular wall.23
The residence time of platelets in the shear field of the
ump tubing is several orders of magnitude shorter than the
0 seconds or more required for shear-induced platelet
ggregation in vitro.24 It is compatible, however, with the
hort residence time (49 ms) in an in vivo study where we
artially compressed a shunt tube with a small static oc-
luder,8 creating a fixed shear stress of 231 dynes/cm2.
hear stress–induced platelet aggregation with short resi-
ence times seems more in line with the clinical situation in
hich thrombosis results from aggregation of platelets that
ass the high shear field of an arterial stenosis or obstructed
tent.19,25 The lower sensitivity of platelets for very short
eriods of shear stress in vitro might be caused by the use of
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Pitrate as anticoagulant because pump perfusion does not
nduce platelet aggregation when the blood has been anti-
oagulated with citrate instead of heparin.4
The experiments with single roller compression revealed
remarkable phenomenon: about 50 ms of high shear stress
ere sufficient to elicit platelet aggregation for at least 28
econds when measured at 15 cm distance from the pump
nd for even 143 seconds when measured at 75 cm distance.
n explanation for this ongoing aggregation is suggested by
easurements of aggregate velocity. This velocity was initially
ower than mean blood velocity, indicating that the aggregates
Figure 5. During pumping many, sometimes even very l
under the influence of 10 mmol/L EDTA. A, Before pump
were microscopically inspected in a Bürker countingoved close to the tube wall. Close contact with the tube wall i
The Journal of Thoracicould have been mediated by vWf, which is known to adhere
ven to coated material.14,26,27 The low initial velocity of the
ggregates might enable them to also activate other, unstimu-
ated platelets that pass by more centrally.
linical Interest
agnitude and duration of calculated shear stresses during
umping were of the same order in a clinically used roller
ump and in our small pump (see Figure 5), suggesting that
he dimensional characteristics of the pump are not decisive.
oreover, aggregation could also be evoked (though less
, aggregates are formed (B and C) that disintegrate (D)
Individual platelets (small black dots) and aggregates
ber.arge
ing.
chamntensively) by nonocclusive compression and by compress-
and Cardiovascular Surgery ● Volume 131, Number 4 819
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CSPng the tube with the fingers (not shown). Also, the material
f the tubing or the presence of coating did not matter. The
resent results therefore strongly suggest that a similar shear
tress–induced platelet aggregation will be evoked by other
oller pumps used in hemodialysis, cardiopulmonary bypass
urgery (CPB), and extracorporeal membrane oxygenation,
nd also in centrifugal pumps in which shear stress may
each values between 400 and 2730 dynes/cm2.28
In our experimental setup these pump effects could be
revented with clopidogrel. In cardiovascular surgery, how-
ver, clopidogrel has been reported to cause excessive
leeding,29 especially when combined with use of aspirin.30
herefore, in the clinic ADP antagonists with a much shorter
alf-life than clopidogrel might be required. Alternatively,
ump-induced platelet aggregation might be prevented, as can
educed from Figure 6, by reversible inhibition of platelet
PIIb/IIIa or GPIb receptor activity,31 vWf-GPIb receptor
inding, or by making the blood calcium-free during its pas-
age through the circuit, as in citrate hemodialysis.32
It remains to be determined how much pump-induced
vWf
aggregation by
 stimulation  of
 other platelets
Ca2+
dense
granules
ADP
5-HT
P2Y1
vasodilation vasoconstriction
clopidogrel
ata
P2Y12
GP 1b
⊗
⊗
alpha
granules
P2Y1
GP
 IIb-IIIa
Shear stress unfolds
  A1- and RGD-domain
of  vWf
RGD A1vWf
P2Y12
GP
 IIb-IIIa
⊗
Ca2+
igure 6. Supposed mechanism of pump-induced platelet aggre-
ation, based on results of the present and previous studies3,5 and
n literature about shear stress–induced platelet aggregation.
hear stress causes a conformational change of plasma vWf and
ossibly a deformation of platelets. Binding of the exposed vWf
1 domain to platelet GPIb receptors triggers intracellular cal-
ium (Ca2) mobilization with subsequent release of ADP and
-HT from dense granules and of vWf from alpha granules. Al-
hough 5-HT mainly has cardiovascular effects, ADP stimulates
2Y12 receptors on the same and other platelets to activate
PIIB/IIIA receptors that bind fibrinogen and vWf, which causes
ggregation. The cascade of events can be interrupted (R) by
urintricarboxylic acid (ata) and by clopidogrel.latelet aggregation contributes to post-CPB complications
20 The Journal of Thoracic and Cardiovascular Surgery ● Apriompared to the important effects of other factors like
lood-air contact and retransfusion of cardiotomy blood
ith subsequent generation of thrombin.33 We conclude that
se of a roller pump in extracorporeal circuits generates
hort bouts of high shear stress that initiate ADP-dependent
latelet aggregation and hypotension, which can be pre-
ented by blocking ADP-P2Y12 receptors with clopidogrel.
hese effects could partially explain the complications seen
n clinical extracorporeal circulation.
We thank Dr. M.A. Vis for developing a mathematical model
o estimate shear stress in the pump tubing and Dr. R. Musters for
reparing the photographic pictures of platelets and their aggre-
ates in a Bürker counting chamber.
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CSP-Appendix
stimation of Wall Shear Stresses During
ear-maximal Tube Compression in a Roller Pump
n a roller pump, flow is generated by repetitive forward squeezing of
he peristaltic tube by a roller, as schematically shown in E Appendix
igure 1, A. Each time a roller gradually releases the tube, another
oller starts the next compression. During progressive compression,
he cross-sectional area in the tube under the roller becomes smaller
nd smaller, and flow velocity in this area increases. Under the
eleasing roller the reverse happens. It is to be expected that the shear
tresses in the blood will be highest just before complete occlusion of
he tube and shortly after reopening. At these moments the cross
ection of the tube takes the form of a slit (see E Appendix Figure 1,
). The wall of this slit can be regarded to consist of 2 parallel flat
lates. Because at small slit heights the Reynolds numbers are low, the
ow in the slit approximates a laminar Poiseuille flow, and a least
stimate of the fluid shear stresses at the wall of the slit can be
alculated from the flow through the slit, the width and height of the
lit, and blood viscosity (3.6 · 103 · Pa · s).
For flow between two parallel plates wall shear stress can be
alculated from the Navier-Stokes equations.1 If a one-directional
iscous flow is assumed, fluid shear stress () is defined as the local
elocity gradient multiplied by fluid viscosity ():
  
dU
dz
here U is velocity, while the z-axis (z) is vertically perpendicular
o the flow direction (see Figure 2).
In a previous study with a static double-plate occluder,2 we
ave shown that, after adaptation of this equation for volume flow,
he maximum shear stress at the slit wall can be calculated as:
Appendix Figure 1. Longitudinal (A) and cross-sectional view (B)
f the tube compressed to a slit by one of the rollers of a pump. x, y,
nd z, Directions along and horizontally and vertically perpendicular
o the tube centerline, respectively; R, roller radius; D, inner diameter
f undeformed tube; h, distance of center of roller to lower point of
ube inner wall; WT, tube wall thickness; d, midline vertical diam-
ter of tube during compression; t, time; w, width of slit.D
21.e1 The Journal of Thoracic and Cardiovascular Surgery ● Ap  
6Q
wd2
here Q is the volume flow, w the slit width, and d the slit height.
n a roller pump these parameters are, during near-maximal tube
ompression, place- and time-dependent:
x, t
6Qx, t
wx, tdx, t2
here x is the place along the tube (see figure) and t is time. The
hree parameters are derived as shown below.
Slit height. The height of the slit d at position x along the
enterline (see E Appendix Figure 1, A), at time t is described by
dx, tminbx, t, D
here b is the inner diameter of the tube right below the roller, and
Appendix Figure 2. Wall shear stresses in the tubing of a small
ump used in a rat study (A, 8 rollers) and in an AK 10 Gambro
emodialysis pump (B, 2 rollers). The lower horizontal axis depicts
he time before or after complete occlusion; the upper horizontal
xis indicates the slit height under a roller. The dotted line repre-
ents the level above which platelet aggregation can be expected.
APPENDIX TABLE. Characteristics of two roller pumps
sed in the model for shear stress estimation
Small pump Clinical pump
otator radius (mm) 15.5 41
otation rate (revol/min) 20 20
umber of rollers 8 2
oller radius (mm) 3 11
ube inner diameter (mm) 1.65 8.1
ube wall thickness (mm) 0.88 1.9the diameter of the undeformed tube.
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Px, th(t)(RWT)2(xl(t))2 if xlt2RWT2
therwise b(x, t) D
ere, R is the radius of the roller, WT is the tube wall thickness,
nd h and l are the z- and x-coordinates of the center of the roller
s a function of time. They are given by
ht RWTmin0, VV t and lt VHt
here VV and VH are the velocity of the roller in vertical and
orizontal direction, respectively, as derived from the rotation rate,
otator radius, and tube inner diameter.
Slit width. It is likely that during tube deformation its inner
ircumference will practically remain constant (see E Appendix
igure 1, B). For the situation where d is far smaller than D, the
lit width at position x and time t can then be approximated () by
wx, t 

2 D dx, t
Volume flow. We calculated Q(x,t) from the maximal flow
max and its repetitive diminishment. Maximal blood flow Qmax
hrough the tube occurs when the occluding roller squeezes the
lood forward while none of the other rollers partially compresses
he tube. The value for Qmax can simply be calculated by multi-
lying the horizontal roller velocity (ie, along the tube), with the
uminal cross-sectional area of the undeformed tube:
Qmax

4
D2VH
Apart from the maximal flow, there is a repetitive diminishment
f flow, starting when a roller other than the occluding roller
egins or ends its compression. To calculate this flow diminish-
ent, the luminal cross-sectional area of the slit at position x andime t, A(x, t), should be known.
The Journal of Thoracic aBecause the slit consists of three parts—a rectangle with width
(x, t), complemented at both sides by two half circles with diameter
(x, t) (see E Appendix Figure 1, B)—A(x, t) can be calculated as
ollows:
Ax, t · D · dx, t2  dx, t24 
Volume flow Q(x,t) is then obtained by the difference of
aximal flow and flow diminishment:
Qx, t Qmax 
x0
x Ax, t
 t
dx
here the diminishment in flow has been calculated by integrating
he rate of change of cross-sectional area between any position x0,
hich lies between the roller under consideration and its prede-
essor or successor, and position x.
pplication of the Model
ime-varying shear stress values were estimated for a small lab-
ratory pump used in rat experiments and for a pump used in
linical hemodialysis. The characteristics of the 2 pumps are given
n E Appendix Table 1). Flow is set at 3% to 5% of cardiac output,
hat is, 3 mL/min for the small pump and 225 mL/min for the AK
0 hemodialysis pump (Gambro). The results are presented in E
ppendix Figure 2.
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